Top compounds associated with response to LILRA2


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC -0.13 0.0007
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0007
mRNA BMS-536924 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC 0.13 0.001
mRNA BRD9647 CTRPv2 pan-cancer AAC -0.13 0.001
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA AZD7762 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA AT7867 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA Teniposide CTRPv2 pan-cancer AAC 0.13 0.002
Download CSV